Media stories about IMS Health (NYSE:IMS) have been trending somewhat positive this week, according to Accern Sentiment. Accern scores the sentiment of media coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. IMS Health earned a news impact score of 0.21 on Accern’s scale. Accern also assigned news coverage about the information technology services provider an impact score of 43.2902422360666 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near term.
IMS Health (NYSE:IMS) traded up $0.99 during midday trading on Friday, reaching $31.34. 4,031,300 shares of the company’s stock traded hands, compared to its average volume of 1,266,943. The company has a current ratio of 1.12, a quick ratio of 1.12 and a debt-to-equity ratio of 2.53. IMS Health has a twelve month low of $22.36 and a twelve month high of $31.59. The stock has a market capitalization of $10,330.00 and a price-to-earnings ratio of 74.62.
IMS Health Company Profile
IMS Health Holdings, Inc (IMS) is an information and technology services company that provides solutions to its clients in the healthcare industry. The Company has its presence in over 100 countries. The Company’s data set contains over 10 petabytes of data and over 500 million patient records. It serves healthcare organizations and life science companies, including pharmaceutical, biotechnology, consumer health and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers and the financial community.
What are top analysts saying about IMS Health? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for IMS Health and related companies.